ACADIA wins MJFF grant to develop Parkinson’s disease therapy
The $322,000 grant is a supplemental award to expand on promising initial research conducted by ACADIA under an earlier grant from MJFF. The new grant is intended to
Kyowa Kirin subsidiary Kyowa Kirin EMEA has received approval from the European Commission (EC) to expand the use of Crysvita (burosumab) for treating X-linked hypophosphataemia (XLH) in infants aged one month to one year across the EU and European Economic Area.
The solution leverages LabConnect’s software, SampleREACH, which provides web-based sample tracking including collection, shipment, and receipt at any laboratory or location worldwide. The software enables instant accessioning and
The automated software systems will replace previous manual, paper-based CAPA and complaints processes, the Pharmaceutical Associates said. Pilgrim’s CAPA Management and Complaints Management form a closed-loop system that